Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-11-17-Speech-1-075"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-11-17"^^xsd:date2
dcterms:Is Part Of	lp_eu:Integrating and strengthening the European research area (2002-2006)2
dcterms:Language	"sv"^^xsd:language2
lpv:document identification number	"en.20031117.6.1-075"2
lpv:hasSubsequent	lp_eu:2003-11-17-Speech-1-0762
lpv:speaker	lp:Astrid Thors2
lpv:spokenAs	substitute; Committee on Legal Affairs and the Internal Market (2002-01-17--2004-07-19)3,3 unknown; Svenska folkpartiet (1999-07-20--2004-07-19)3,3 vice-chair; PETI (2002-01-23--2004-07-19)3,3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3,3 substitute; Delegation to the European Economic Area Joint Parliamentary Committee (EEA) (2002-02-07--2004-07-19)3,3 member; Delegation to the EU-Latvia Joint Parliamentary Committee (2002-02-07--2004-04-30)3,3 member_of_the_bureau; ELDR (1999-07-20--2004-07-19)3,3
lpv:translated text	"Mr President, Commissioner, I wrote the draft opinion of the Committee on Legal Affairs and the Internal Market. Because the majority of the committee differs from the majority in Parliament and because the right is considerably over-represented, the opinion took, however, a form I was unable to accept. I did not, therefore, want my name to appear on it. My legal analysis differs totally from that presented by the committee chairman, Mr Gargani. Firstly, there are no obstacles to this research under the Oviedo Convention. Secondly, I have to say that Mr Gargani’s analysis of what the research programmes mean in legal terms was also completely irrelevant. It was a very long way from the truth. I also observe in my proposal that the European Group for Ethics, of which the Commission and ourselves can make use, has not excluded embryonic stem cell research. What is the point of an advisory group if we do not listen to it? For me, as for many others, the most important ethical issue is about reducing human suffering. That is something we can do if, in regulated and open ways, we try to cooperate and to do what many speakers have said we must in order to reduce suffering through diseases such as Alzheimer’s and Parkinson’s. We must have public funding, and the funding must be European if the results are to be made available to all Europeans. I should, however, have liked to have seen the time limit removed from the Commission’s proposal. It is not justified on ethical grounds. I view with great satisfaction the committee’s Amendment 11 about removing the demand that all alternative methods must have been examined. It leaves room for a very great deal of arbitrariness, and I support what has been said by Mrs Plooij-van Gorsel, Mr Bowe and others."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph